Amedeo's Top 20

Amedeo Smart

Independent Medical Education

26 December 2022

Multidisciplinary Journal Club

  1. Rahangdale L, Mungo C, O'Connor S, Chibwesha CJ, et al.
    Human papillomavirus vaccination and cervical cancer risk.
    BMJ 2022;379:e070115.

  1. Mok J, Lee M, Kim DK, Kim JS, et al.
    9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3
    Lancet 2022;400:1522-1530.

  2. Ahluwalia MS, Reardon DA, Abad AP, Curry WT, et al.
    Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.
    J Clin Oncol 2022.

  3. Brenowitz WD, Fornage M, Launer LJ, Habes M, et al.
    Alzheimer's disease genetic risk, cognition, and brain aging in midlife.
    Ann Neurol 2022.

  4. Messier SP, Beavers DP, Queen K, Mihalko SL, et al.
    Effect of Diet and Exercise on Knee Pain in Patients With Osteoarthritis and Overweight or Obesity: A Randomized Clinical Trial.
    JAMA 2022;328:2242-2251.

  1. Sacco S, Harriott AM, Ayata C, Ornello R, et al.
    Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology 2022.

  2. Stirling RE, Hidajat CM, Grayden DB, D'Souza WJ, et al.
    Sleep and seizure risk in epilepsy: bed and wake times are more important than sleep duration.
    Brain 2022.

  3. Ettleson MD, Prieto WH, Russo PST, de Sa J, et al.
    Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-Treated Patients.
    J Clin Endocrinol Metab 2022.

  4. El Sharouni MA, Rawson RV, Potter AJ, Paver EC, et al.
    Melanomas in children and adolescents: clinicopathologic features and survival outcomes.
    J Am Acad Dermatol 2022.

  5. Hurvitz SA, Hegg R, Chung WP, Im SA, et al.
    Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
    Lancet 2022.

  1. Kappelman MD, Adimadhyam S, Hou L, Wolfe AE, et al.
    Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease.
    Am J Gastroenterol 2022.

  2. Nastoupil LJ, Bartlett NL.
    Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma.
    J Clin Oncol 2022.

  3. Chang CJ, O'Brien KM, Keil AP, Gaston SA, et al.
    Use of Straighteners and Other Hair Products and Incident Uterine Cancer.
    J Natl Cancer Inst 2022;114:1636-1645.

  4. Acosta MB, Fernandez-Clotet A, Mesonero F, Garcia-Alonso FJ, et al.
    Long-term outcomes of biological therapy in Crohn's disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU.
    Am J Gastroenterol 2022.

  5. Onderwater GLJ, van Dongen RM, Harms AC, Zielman R, et al.
    Cerebrospinal fluid and plasma amine profiles in interictal migraine.
    Ann Neurol 2022.

  1. Pagani O, Walley BA, Fleming GF, Colleoni M, et al.
    Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
    J Clin Oncol 2022.

  2. Ekker MS, Verhoeven JI, Schellekens MMI, Boot EM, et al.
    Risk Factors and Causes of Ischemic Stroke in 1322 Young Adults.
    Stroke 2022.

  3. Damluji AA, Forman DE, Wang TY, Chikwe J, et al.
    Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation 2022.

  4. Hollenberg SM, Janz DR, Hua M, Malesker M, et al.
    COVID-19: Lessons Learned, Lessons Unlearned, Lessons for the Future.
    Chest 2022;162:1297-1305.

  5. Rueda Garcia JL, Suarez Ferrer C, Martin-Arranz E, Garcia-Ramirez L, et al.
    Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial.
    Scand J Gastroenterol 2022.


more..

Privacy Policy